Best Over-the-Counter CGM in 2026: 3 OTC Devices Compared

Over-the-counter continuous glucose monitors became available in the United States in 2024, creating an entirely new product category. These OTC CGMs require no prescription, no doctor visit, and no insurance — you can order them online or pick them up at a pharmacy just like a blood pressure cuff. As of 2026, 4 OTC glucose monitors are available: the Dexcom Stelo ($49 to $99/month), Abbott Lingo ($49/month), Abbott Libre Rio ($49/month), and SIBIONICS CGM ($30 to $60/month in international markets). None of these devices are intended for diabetes management, insulin dosing, or use with insulin pumps.

The key distinction between OTC and prescription CGMs is the absence of safety-critical features. Over-the-counter monitors do not provide customizable high/low glucose alerts, predictive urgent low alarms, insulin pump integration, or data sharing with healthcare providers. They are designed for glucose awareness — showing you how food, exercise, and sleep affect blood sugar — not for managing a medical condition that requires real-time alerts to prevent dangerous events. If you take insulin or sulfonylureas, an OTC CGM is not appropriate for your needs. The FDA created a separate regulatory pathway for OTC CGMs in 2024, and each device carries a specific indication for general wellness or weight management rather than diabetes treatment.

The Dexcom Stelo is the best OTC CGM for data-driven users who want detailed glucose analytics, a polished app experience, and 15-day wear time. The Abbott Lingo is the best value at $49/month with a coaching-focused approach ideal for beginners. The Abbott Libre Rio is the only OTC CGM FDA-cleared for weight management and is the top pick for users on GLP-1 medications.